Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Hum Reprod. 2013 Dec;28(12):3292-300. doi: 10.1093/humrep/det358. Epub 2013 Sep 18.
Is there a shift in the timing of nucleolar channel system (NCS) formation following controlled ovarian hyperstimulation (COH)?
NCSs appear prematurely following COH compared with natural cycles.
During natural cycles, NCSs of endometrial epithelial cell (EEC) nuclei are exclusively present during the window of implantation and are uniformly distributed throughout the upper endometrial cavity.
STUDY DESIGN, SIZE, DURATION: Prospective two-cohort study. Cohorts I and II each consisted of seven volunteers for the duration of three menstrual study cycles that were separated by at least one wash-out or rest cycle, between December 2008 and May 2012.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Participants were recruited from a pool of healthy oocyte donors. Consecutive endometrial biopsies were obtained during the same luteal phase on cycle days (CD) 16, 20 and 26 for Cohort I, and on CD14, 22 and 24 for Cohort II, following random assignment to a natural cycle group, a COH cycle group (using a GnRH antagonist), or a COH cycle group receiving luteal phase hormonal supplementation (COH + S). The day of oocyte retrieval was designated CD14 in COH cycles and the day of the LH surge was designated CD13 in natural cycles. Prevalence of NCSs in the nuclei of EECs was quantified using indirect immunofluorescence with an antibody directed against a subset of related nuclear pore complex proteins that are major constituents of NCSs. Progesterone and estradiol levels were measured on the day of each endometrial biopsy.
The natural cycle group exhibited peak NCS prevalence on CD20 [53.3%; interquartile range (IQR) 28.5-55.8], which rapidly declined on CD22 (11.8%; IQR 6.3-17.6), CD24 (2.5%; IQR 0.0-9.2) and CD26 (0.3%; IQR 0.0-3.5), and no NCSs on CD14 and 16 defining a short NCS window around CD20. In contrast, in COH and COH + S cycles, NCS prevalence was high already on CD16 (40.4%; IQR 22.6-53.4 and 35.6%; IQR 26.4-44.5, respectively; P = 0.001 compared with CD16 of the natural cycle group, Mann-Whitney), whereas no significant difference in NCS prevalence was detected on any of the other five CDs between the three groups (P > 0.05).
LIMITATIONS, REASONS FOR CAUTION: The cohort size was small (n = 7) but was offset by the all-or-none presence of NCSs on CD16 in natural versus COH and COH + S cycles and the fact that each subject served as her own control.
Premature appearance of NCSs and hence maturation of the endometrium following COH is consistent with previous studies based on histological dating but contradicts studies based on mRNA expression profiling, which reported a lag in endometrial maturation. However, this is the first study of this kind that is based on consecutive endometrial biopsies within the same cycle and that reports such clear-cut differences: no versus robust NCS presence on CD16. Our observation of advanced endometrial maturation following COH may contribute to the reduced implantation rates seen in fresh compared with frozen and donor IVF-embryo transfer cycles. Therefore, the NCS window could serve as a sensitive guide for timing of embryo transfer in frozen and donor cycles.
STUDY FUNDING/COMPETING INTEREST(S): The study was supported by the March of Dimes Birth Defects foundation (1-FY09-363 to U.T.M.); Ferring Pharmaceuticals, Parsippany, NJ; East Coast Fertility, Plainview, NY and the CMBG Training Program (T32 GM007491 to M.J.S.). We report no competing interests.
控制性卵巢超刺激(COH)后是否会改变核仁通道系统(NCS)形成的时间?
与自然周期相比,COH 后 NCS 出现得更早。
在自然周期中,子宫内膜上皮细胞(EEC)核的 NCS 仅在着床窗口期存在,并且均匀分布在上子宫内膜腔中。
研究设计、大小、持续时间:前瞻性两队列研究。队列 I 和 II 各由 7 名志愿者组成,持续 3 个月经研究周期,每个周期之间至少有一个洗脱或休息周期,研究时间为 2008 年 12 月至 2012 年 5 月。
参与者/材料、设置、方法:参与者从一组健康的卵母细胞供体中招募。在自然周期组、COH 周期组(使用 GnRH 拮抗剂)或接受黄体期激素补充的 COH 周期组(COH + S)中,随机分配后,在 CD16、20 和 26 日取同一黄体期的连续子宫内膜活检。COH 周期中取卵日为 CD14 日,自然周期中 LH 峰日为 CD13 日。使用针对核孔复合体蛋白亚组的间接免疫荧光法来量化 EEC 核中 NCS 的存在情况,核孔复合体蛋白是 NCS 的主要组成部分。在每次子宫内膜活检当天测量孕酮和雌二醇水平。
自然周期组在 CD20 时表现出 NCS 患病率的峰值[53.3%;四分位间距(IQR)28.5-55.8],随后在 CD22(11.8%;IQR 6.3-17.6)、CD24(2.5%;IQR 0.0-9.2)和 CD26(0.3%;IQR 0.0-3.5)迅速下降,CD14 和 16 上没有 NCSs,定义了 CD20 周围的短 NCS 窗口。相比之下,在 COH 和 COH + S 周期中,NCS 患病率在 CD16 时已经很高(分别为 40.4%;IQR 22.6-53.4 和 35.6%;IQR 26.4-44.5;P = 0.001 与自然周期组的 CD16 相比,Mann-Whitney),而在三组之间的其他五个 CD 上,NCS 患病率没有显著差异(P > 0.05)。
局限性、谨慎的原因:队列规模较小(n = 7),但与自然周期与 COH 和 COH + S 周期相比,CD16 上 NCS 的全有或全无存在以及每个受试者作为自己的对照相抵消。
COH 后 NCS 的早期出现以及子宫内膜的成熟与之前基于组织学日期的研究一致,但与基于 mRNA 表达谱的研究相矛盾,后者报告子宫内膜成熟滞后。然而,这是第一个基于同一周期内连续子宫内膜活检的此类研究,并且报告了如此明显的差异:在 CD16 上没有或有强烈的 NCS 存在。我们观察到 COH 后子宫内膜成熟度提高,这可能导致新鲜周期与冷冻和供体 IVF-胚胎移植周期相比,着床率降低。因此,NCS 窗口可以作为冷冻和供体周期中胚胎移植时间的敏感指南。
研究基金/利益冲突:该研究由 March of Dimes 出生缺陷基金会(1-FY09-363 至 U.T.M.);费森尤斯制药公司,帕西潘尼,新泽西州;东海岸生育,普莱恩维尤,纽约和 CMBG 培训计划(T32 GM007491 至 M.J.S.)资助。我们没有报告任何利益冲突。